Question & Answer About Cogen Biosciences Question From Mel Nashef   Q: On November 24, 2025, you posted news about a biotech company called Cogent Biosciences (COGT). In it you wrote that the firm has positive data from Phase 3 PEAK Trial in combination of its drug . . . This content is for paid subscribers. Please click here to subscribe or here to log in.

Cogent Biosciences Excellent NEWS Cogent Biosciences (COGT) develops precision therapies for patients with genetically defined diseases. The Company’s primary focusses target different forms of mastocytosis and gastrointestinal stomal tumors (GIST). The firm’s positive data from Phase 3 PEAK Trial has been studied with the combination of its drug bezuclastinib with Sunitinib. Many analysts . . . This content is for paid subscribers. Please click here to …